Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Efficacy and safety of medical cannabinoids in older subjects: a systematic review.

van den Elsen GA, Ahmed AI, Lammers M, Kramers C, Verkes RJ, van der Marck MA, Rikkert MG.

Ageing Res Rev. 2014 Mar;14:56-64. doi: 10.1016/j.arr.2014.01.007. Epub 2014 Feb 5. Review.

PMID:
24509411
2.

Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.

Whiting PF, Wolff RF, Deshpande S, Di Nisio M, Duffy S, Hernandez AV, Keurentjes JC, Lang S, Misso K, Ryder S, Schmidlkofer S, Westwood M, Kleijnen J.

JAMA. 2015 Jun 23-30;313(24):2456-73. doi: 10.1001/jama.2015.6358. Review. Erratum in: JAMA. 2016 Apr 12;315(14):1522. Erratum in: JAMA. 2015 Aug 4;314(5):520. JAMA. 2015 Aug 25;314(8):837. JAMA. 2015 Dec 1;314(21):2308.

PMID:
26103030
3.
4.

Cannabinoids for the treatment of dementia.

Krishnan S, Cairns R, Howard R.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD007204. doi: 10.1002/14651858.CD007204.pub2. Review.

PMID:
19370677
5.

Medical Cannabinoids in Children and Adolescents: A Systematic Review.

Wong SS, Wilens TE.

Pediatrics. 2017 Nov;140(5). pii: e20171818. doi: 10.1542/peds.2017-1818. Review.

PMID:
29061872
6.

Cannabinoids: Medical implications.

Schrot RJ, Hubbard JR.

Ann Med. 2016;48(3):128-41. doi: 10.3109/07853890.2016.1145794. Epub 2016 Feb 25. Review.

PMID:
26912385
7.

Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review.

Tramèr MR, Carroll D, Campbell FA, Reynolds DJ, Moore RA, McQuay HJ.

BMJ. 2001 Jul 7;323(7303):16-21. Review.

8.

Cannabinoids for Tourette's Syndrome.

Curtis A, Clarke CE, Rickards HE.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD006565. doi: 10.1002/14651858.CD006565.pub2. Review.

PMID:
19821373
9.

[Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review].

Volz MS, Siegmund B, Häuser W.

Schmerz. 2016 Feb;30(1):37-46. doi: 10.1007/s00482-015-0087-0. Review. German.

PMID:
26809974
10.

Efficacy and adverse effects of medical marijuana for chronic noncancer pain: Systematic review of randomized controlled trials.

Deshpande A, Mailis-Gagnon A, Zoheiry N, Lakha SF.

Can Fam Physician. 2015 Aug;61(8):e372-81. Review.

11.

Adverse effects of medical cannabinoids: a systematic review.

Wang T, Collet JP, Shapiro S, Ware MA.

CMAJ. 2008 Jun 17;178(13):1669-78. doi: 10.1503/cmaj.071178. Review.

12.

Cannabis in cancer care.

Abrams DI, Guzman M.

Clin Pharmacol Ther. 2015 Jun;97(6):575-86. doi: 10.1002/cpt.108. Epub 2015 Apr 17. Review.

13.

Cannabinoids in treatment-resistant epilepsy: A review.

O'Connell BK, Gloss D, Devinsky O.

Epilepsy Behav. 2017 May;70(Pt B):341-348. doi: 10.1016/j.yebeh.2016.11.012. Epub 2017 Feb 8. Review.

PMID:
28188044
14.

Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review.

Campbell FA, Tramèr MR, Carroll D, Reynolds DJ, Moore RA, McQuay HJ.

BMJ. 2001 Jul 7;323(7303):13-6. Review.

15.

Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review.

Hill KP.

JAMA. 2015 Jun 23-30;313(24):2474-83. doi: 10.1001/jama.2015.6199. Review. Erratum in: JAMA. 2016 Sep 6;316(9):995.

PMID:
26103031
16.

Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain.

Iskedjian M, Bereza B, Gordon A, Piwko C, Einarson TR.

Curr Med Res Opin. 2007 Jan;23(1):17-24.

PMID:
17257464
17.

[Potential applications of marijuana and cannabinoids in medicine].

Zdrojewicz Z, Pypno D, Cabała K, Bugaj B, Waracki M.

Pol Merkur Lekarski. 2014 Oct;37(220):248-52. Review. Polish.

PMID:
25518584
18.

[There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis].

Basinski H, Jensen HB, Stenager E.

Ugeskr Laeger. 2014 Mar 17;176(12A). pii: V09130552. Review. Danish.

PMID:
25350886
19.
20.

Medical marijuana in neurology.

Benbadis SR, Sanchez-Ramos J, Bozorg A, Giarratano M, Kalidas K, Katzin L, Robertson D, Vu T, Smith A, Zesiewicz T.

Expert Rev Neurother. 2014 Dec;14(12):1453-65. doi: 10.1586/14737175.2014.985209. Review.

PMID:
25427150

Supplemental Content

Support Center